The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feet

J. Leslie Redpath, Martin Colman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effects of adriamycin (10 mg/kg, i.p.) and actinomycin D (0.7 mg/kg, i.p.) on radiation-induced skin reactions in mouse feet have been examined. Drugs were administered either 24 or 2 hr before, or 24 hr after single doses of 6 MeV photons. Split radiation dose experiments were also performed with the drug being administered either 24 or 2 hr before the first radiation dose. A five daily fraction experiment with drug administered 2 hr before the first and third doses was also carried out. In none of these experiments did adriamycin alter the kinetics of appearance, or the severity of, the radiation-induced reaction. Furthermore, drug administered 30 days after the radiation dose, i.e. after the radiation reaction was healed, did not induce any further reaction. These results confirm our previous preliminary observations that adriamycin does not significantly enhance radiation damage to the skin of mouse feet. In the case of actinomycin D no enhancement of skin reaction in single radiation dose experiments was observed. However, in both the split dose and five fraction study a significantly more severe skin reaction was seen in the drug treated animals compared to those treated with radiation alone.

Original languageEnglish (US)
Pages (from-to)483-486
Number of pages4
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume5
Issue number4
DOIs
StatePublished - 1979
Externally publishedYes

Fingerprint

actinomycin
Dactinomycin
Doxorubicin
mice
Foot
Radiation
Skin
dosage
radiation
drugs
Pharmaceutical Preparations
radiation damage
Photons
animals

Keywords

  • Actinomycin D
  • Adriamycin
  • Skin reactions
  • X-ray

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feet. / Leslie Redpath, J.; Colman, Martin.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 5, No. 4, 1979, p. 483-486.

Research output: Contribution to journalArticle

@article{d7b08b6620894d4b89fbef6128717e4a,
title = "The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feet",
abstract = "The effects of adriamycin (10 mg/kg, i.p.) and actinomycin D (0.7 mg/kg, i.p.) on radiation-induced skin reactions in mouse feet have been examined. Drugs were administered either 24 or 2 hr before, or 24 hr after single doses of 6 MeV photons. Split radiation dose experiments were also performed with the drug being administered either 24 or 2 hr before the first radiation dose. A five daily fraction experiment with drug administered 2 hr before the first and third doses was also carried out. In none of these experiments did adriamycin alter the kinetics of appearance, or the severity of, the radiation-induced reaction. Furthermore, drug administered 30 days after the radiation dose, i.e. after the radiation reaction was healed, did not induce any further reaction. These results confirm our previous preliminary observations that adriamycin does not significantly enhance radiation damage to the skin of mouse feet. In the case of actinomycin D no enhancement of skin reaction in single radiation dose experiments was observed. However, in both the split dose and five fraction study a significantly more severe skin reaction was seen in the drug treated animals compared to those treated with radiation alone.",
keywords = "Actinomycin D, Adriamycin, Skin reactions, X-ray",
author = "{Leslie Redpath}, J. and Martin Colman",
year = "1979",
doi = "10.1016/0360-3016(79)90810-1",
language = "English (US)",
volume = "5",
pages = "483--486",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feet

AU - Leslie Redpath, J.

AU - Colman, Martin

PY - 1979

Y1 - 1979

N2 - The effects of adriamycin (10 mg/kg, i.p.) and actinomycin D (0.7 mg/kg, i.p.) on radiation-induced skin reactions in mouse feet have been examined. Drugs were administered either 24 or 2 hr before, or 24 hr after single doses of 6 MeV photons. Split radiation dose experiments were also performed with the drug being administered either 24 or 2 hr before the first radiation dose. A five daily fraction experiment with drug administered 2 hr before the first and third doses was also carried out. In none of these experiments did adriamycin alter the kinetics of appearance, or the severity of, the radiation-induced reaction. Furthermore, drug administered 30 days after the radiation dose, i.e. after the radiation reaction was healed, did not induce any further reaction. These results confirm our previous preliminary observations that adriamycin does not significantly enhance radiation damage to the skin of mouse feet. In the case of actinomycin D no enhancement of skin reaction in single radiation dose experiments was observed. However, in both the split dose and five fraction study a significantly more severe skin reaction was seen in the drug treated animals compared to those treated with radiation alone.

AB - The effects of adriamycin (10 mg/kg, i.p.) and actinomycin D (0.7 mg/kg, i.p.) on radiation-induced skin reactions in mouse feet have been examined. Drugs were administered either 24 or 2 hr before, or 24 hr after single doses of 6 MeV photons. Split radiation dose experiments were also performed with the drug being administered either 24 or 2 hr before the first radiation dose. A five daily fraction experiment with drug administered 2 hr before the first and third doses was also carried out. In none of these experiments did adriamycin alter the kinetics of appearance, or the severity of, the radiation-induced reaction. Furthermore, drug administered 30 days after the radiation dose, i.e. after the radiation reaction was healed, did not induce any further reaction. These results confirm our previous preliminary observations that adriamycin does not significantly enhance radiation damage to the skin of mouse feet. In the case of actinomycin D no enhancement of skin reaction in single radiation dose experiments was observed. However, in both the split dose and five fraction study a significantly more severe skin reaction was seen in the drug treated animals compared to those treated with radiation alone.

KW - Actinomycin D

KW - Adriamycin

KW - Skin reactions

KW - X-ray

UR - http://www.scopus.com/inward/record.url?scp=0018751580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018751580&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(79)90810-1

DO - 10.1016/0360-3016(79)90810-1

M3 - Article

C2 - 457493

AN - SCOPUS:0018751580

VL - 5

SP - 483

EP - 486

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -